Alzheimer’s Archives

Metabolic News Weekly: November 5, 2024

Novo inks Ascendis deal to develop long-acting GLP-1, other metabolic drugs November 4, 2024 / GLP-1 Drugs / Novo Nordisk Partnership / Obesity Treatment Innovation / Diabetes / Drug Delivery / Cardiometabolic Disease Therapies Novo Nordisk and Ascendis Pharma are...

November 5, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: July 4, 2024

// Biotech and Pharma Therapeutics CDC looks to expand capacity to test for H5N1 bird flu in people July 2, 2024 / H5N1 Bird Flu Testing / CDCCDC plans to enhance testing for H5N1 bird flu in humans, as the...

July 4, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: May 23, 2024

// Biotech and Pharma Therapeutics Regeneron faces new biosimilar threats; an AI biotech lays off staff May 22, 2024 / Regeneron Biosimilars / Boehringer Ingelheim / OSE Deal / GSK Regeneron faces new competition from FDA-approved biosimilars for Eylea. Boehringer...

May 23, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 22, 2024

// Biotech and Pharma Therapeutics Phage therapy: Researchers sharpen another arrow in the quiver against antibiotic resistance February 20, 2024 / Antibiotic Resistance / New Drug “It just got so frustrating over the years because we couldn’t find the source,...

February 22, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 19, 2024

// Biotech and Pharma Therapeutics Kyverna sets plans for IPO in test of biotech enthusiasm January 17, 2024 / Kyverna / IPO / Startup More than two years after the bottom fell out for biotech stocks, the market for IPOs...

January 19, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 12, 2024

// Biotech and Pharma Therapeutics CRISPR pioneer Doudna allies with Danaher for gene editing center targeting rare disease and beyond January 9, 2024 / Jennifer Doudna / CRISPR / Danaher / Gene Editing CRISPR pioneer Jennifer Doudna, Ph.D., looks set...

January 12, 2024

Year In Review

Healthcare Industry News 2023 Year in Review: Cardiovascular

// January In January, XyloCor’s gene therapy showed promise for cardiovascular conditions, a reanalysis raised concerns about Amgen’s Repatha, Renibus’ cardiac surgery drug succeeded in a phase 2 trial, and AstraZeneca announced a $1.8 billion acquisition in the cardiovascular field....

December 21, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 1, 2023

// Biotech and Pharma Therapeutics Gain Therapeutics to Participate in AI Driven Drug Discovery Summit November 29, 2023 / AI / Drug Discovery / Gain Therapeutics Gain Therapeutics, Inc., (Nasdaq: GANX), a clinical-stage biotechnology company leading the discovery and development...

December 1, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: November 24, 2023

// Biotech and Pharma Therapeutics To address shortage, Novo Nordisk will cut production of Victoza to boost supply of Ozempic November 22, 2023 / Novo Nordisk / Ozempic / Victoza / Wegovy Unable to scale up its manufacturing fast enough...

November 24, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: November 10, 2023

// Biotech and Pharma Therapeutics AstraZeneca Pays $185M to Add Oral GLP-1 Drug Candidate to Pipeline November 9, 2023 / AstraZeneca / GLP-1 / Metabolic Disorder The available metabolic disorder drugs targeting the GLP-1 receptor are all injectable products. The...

November 10, 2023

1 2 … 5 6

Tag: Alzheimer’s